| [1] |
MCCRIMMON R J. Remembrance of things past: the consequences of recurrent hypoglycaemia in diabetes[J]. Diabet Med, 2022, 39(12): e14973. DOI: 10.1111/dme.14973.
|
| [2] |
SANKAR A, KHODAI T, MCNEILLY A D, et al. Experimental models of impaired hypoglycaemia-associated counter-regulation[J]. Trends Endocrinol Metab, 2020, 31(9): 691-703. DOI: 10.1016/j.tem.2020.05.008.
|
| [3] |
孔玉侠, 董爱梅, 郑嘉堂, 等. 门诊2型糖尿病患者低血糖及其影响因素分析研究[J]. 中国全科医学, 2019, 22(8): 936-941.
|
| [4] |
王俊薇, 管丽华, 邢媛, 等. 社区2型糖尿病及糖尿病前期管理现状调查研究[J]. 中国全科医学, 2021, 24(27): 3439-3443, 3450.
|
| [5] |
RILEY R D, ENSOR J, SNELL K I E, et al. Calculating the sample size required for developing a clinical prediction model[J]. BMJ, 2020, 368: m441. DOI: 10.1136/bmj.m441.
|
| [6] |
ZODPEY S P. Sample size and power analysis in medical research[J]. Indian J Dermatol Venereol Leprol, 2004, 70(2): 123-128.
|
| [7] |
YU X H, FAN M, ZHAO X, et al. Prevalence of impaired awareness of hypoglycaemia in people with diabetes mellitus: a systematic review and meta-analysis from 21 countries and regions[J]. Diabet Med, 2023, 40(9): e15129. DOI: 10.1111/dme.15129.
|
| [8] |
中华医学会糖尿病学分会, 国家基层糖尿病防治管理办公室. 国家基层糖尿病防治管理指南(2022)[J]. 中华内科杂志, 2022, 61(3): 249-262.
|
| [9] |
SEAQUIST E R, ANDERSON J, CHILDS B, et al. Hypoglycemia and diabetes: a report of a workgroup of the American diabetes association and the endocrine society[J]. J Clin Endocrinol Metab, 2013, 98(5): 1845-1859. DOI: 10.1210/jc.2012-4127.
|
| [10] |
王雅静, 方彭华, 张真稳. 2型糖尿病患者低血糖感知受损的研究进展[J]. 国际内分泌代谢杂志, 2023, 43(2): 132-135.
|
| [11] |
高瑞桐. 基于信息框架效应的干预方案对2型糖尿病患者自我管理行为改变的研究[D]. 长春: 吉林大学, 2022.
|
| [12] |
GOMEZ-PERALTA F, FORNOS PÉREZ J A, MOLINERO A, et al. Adherence to antidiabetic treatment and impaired hypoglycemia awareness in type 2 diabetes mellitus assessed in Spanish community pharmacies: the ADHIFAC study[J]. BMJ Open Diabetes Res Care, 2021, 9(2): e002148. DOI: 10.1136/bmjdrc-2021-002148.
|
| [13] |
MACON E L, DEVORE M H, LIN Y K, et al. Current and future therapies to treat impaired awareness of hypoglycemia[J]. Front Pharmacol, 2023, 14: 1271814. DOI: 10.3389/fphar.2023.1271814.
|
| [14] |
LIN Y K, YE W, ROGERS H, et al. Mitigating severe hypoglycemia in users of advanced diabetes technologies: impaired awareness of hypoglycemia and unhelpful hypoglycemia beliefs as targets for interventions[J]. Diabetes Technol Ther, 2024, 26(10): 739-747. DOI: 10.1089/dia.2024.0039.
|
| [15] |
LI X N, KAN Y S, LIU H Y, et al. Prevalence and contributing factors of impaired awareness of hypoglycemia in patients with type 2 diabetes: a meta-analysis[J]. Acta Diabetol, 2023, 60(9): 1155-1169. DOI: 10.1007/s00592-023-02102-2.
|
| [16] |
LEE W K, KO M S M, ANG L C, et al. A real-life comparison of hypoglycaemia symptomatology between insulin-treated type 2 diabetes participants with and without impaired awareness of hypoglycaemia[J]. Diabet Med, 2023, 40(11): e15215. DOI: 10.1111/dme.15215.
|
| [17] |
ZHU L, ANG L C, TAN W B, et al. A study to evaluate the prevalence of impaired awareness of hypoglycaemia in adults with type 2 diabetes in outpatient clinic in a tertiary care centre in Singapore[J]. Ther Adv Endocrinol Metab, 2017, 8(5): 69-74. DOI: 10.1177/2042018817707422.
|
| [18] |
HELLER S R, PEYROT M, OATES S K, et al. Hypoglycemia in patient with type 2 diabetes treated with insulin: it can happen[J]. BMJ Open Diabetes Res Care, 2020, 8(1): e001194. DOI: 10.1136/bmjdrc-2020-001194.
|
| [19] |
CHENG H J, WENG S H, WU J L, et al. Long-term sulfonylurea use and impaired awareness of hypoglycemia among patients with type 2 diabetes in Taiwan[J]. Ann Fam Med, 2024, 22(4): 309-316. DOI: 10.1370/afm.3129.
|
| [20] |
FARRELL C M, MCCRIMMON R J. Clinical approaches to treat impaired awareness of hypoglycaemia[J]. Ther Adv Endocrinol Metab, 2021, 12: 20420188211000248. DOI: 10.1177/20420188211000248.
|
| [21] |
刘晨霄, 胡兴娜, 陈佳奇, 等. 方便门诊糖尿病患者降糖药物知晓率的调查及其影响因素研究[J]. 中华糖尿病杂志, 2022, 14(2): 173-178.
|
| [22] |
龙超, 李佳, 杨智凯, 等. 家庭医生签约服务对糖尿病患者认知、行为和健康结果的影响研究[J]. 中国全科医学, 2025, 28(7): 880-887.
|
| [23] |
WANG Y H, ZENG Z H, DING J, et al. Fear of hypoglycaemia among patients with type 2 diabetes mellitus: a cross-sectional study[J]. Sci Rep, 2021, 11(1): 7971. DOI: 10.1038/s41598-021-86954-0.
|
| [24] |
LIANG D, ZHU W J, HUANG J Y, et al. A health economic analysis of an integrated diabetes care program in China: based on real-world evidence[J]. Front Public Health, 2023, 11: 1211671. DOI: 10.3389/fpubh.2023.1211671.
|
| [25] |
ZHAO R, ZHAO N, WANG S, et al. Assessment of type 2 diabetes mellitus patients' behavioral characteristics associated with integrated treatment and prevention services in community health centers in China[J]. Front Public Health, 2022, 10: 1084946. DOI: 10.3389/fpubh.2022.1084946.
|
| [26] |
HÖLZEN L, SCHULTES B, MEYHÖFER S M, et al. Hypoglycemia unawareness-a review on pathophysiology and clinical implications[J]. Biomedicines, 2024, 12(2): 391. DOI: 10.3390/biomedicines12020391.
|
| [27] |
KHAN T A, FIELD D, CHEN V, et al. Combination of multiple low-risk lifestyle behaviors and incident type 2 diabetes: a systematic review and dose-response meta-analysis of prospective cohort studies[J]. Diabetes Care, 2023, 46(3): 643-656. DOI: 10.2337/dc22-1024.
|
| [28] |
BERRY S A, LIARAKOS A L, KOUTROUKAS V, et al. The challenge of assessing impaired awareness of hypoglycaemia in diabetes in the era of continuous glucose monitoring: a narrative review of evidence and translation into clinical practice[J]. Diabetes Obes Metab, 2025, 27(5): 2363-2376. DOI: 10.1111/dom.16284.
|
| [29] |
HENDRIECKX C, GONDER-FREDERICK L, HELLER S R, et al. How has psycho-behavioural research advanced our understanding of hypoglycaemia in type 1 diabetes?[J]. Diabet Med, 2020, 37(3): 409-417. DOI: 10.1111/dme.14205.
|
| [30] |
HEALEY A, SOUKUP T, SEVDALIS N, et al. Cost-effectiveness of a novel hypoglycaemia programme: the 'HARPdoc vs BGAT' RCT[J]. Diabet Med, 2024, 41(6): e15304. DOI: 10.1111/dme.15304.
|
| [31] |
SHI MIN KO M, LEE W K, LI C A, et al. A Cross-Sectional study on risk factors for severe hypoglycemia among Insulin-Treated elderly type 2 diabetes Mellitus (T2DM) patients in Singapore[J]. Diabetes Res Clin Pract, 2022, 185: 109236. DOI: 10.1016/j.diabres.2022.109236.
|